Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EDTA chelation therapy does not selectively increase chromium losses.

R A Anderson1, N A Bryden, R Waters

  • 1Nutrient Requirements and Functions Laboratory, Beltsville Human Nutrition Research Center, U.S. Department of Agriculture, Agricultural Research Service, MD 20705-2350, USA.

Biological Trace Element Research
|December 28, 1999
PubMed
Summary

Chelation therapy did not increase urinary chromium losses or affect chromium homeostasis. Supplementation, not chelation, significantly influenced chromium levels in urine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Constraints on cosmic strings from the LIGO-Virgo gravitational-wave detectors.

Physical review letters·2014
Same author

Dietary chromium deficiency effect on sperm count and fertility in rats.

Biological trace element research·2013
Same author

Characteristics of enzymes forming 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG) in brain.

Neurochemical research·2013
Same author

Chromium intake and urinary chromium excretion of trauma patients.

Biological trace element research·2013
Same author

Acute effects on chromium, copper, zinc, and selected clinical variables in urine and serum of male runners.

Biological trace element research·2013
Same author

The immature human ovary shows loss of abnormal follicles and increasing follicle developmental competence through childhood and adolescence.

Human reproduction (Oxford, England)·2013

Area of Science:

  • Biochemistry
  • Metabolic Health
  • Toxicology

Background:

  • Chelation therapy and chromium (Cr) supplementation show potential for improving metabolic markers like blood glucose and insulin activity.
  • Chelation therapy involves removing metals, raising questions about its impact on essential minerals like chromium.
  • Understanding chromium homeostasis is crucial for metabolic health management.

Purpose of the Study:

  • To investigate whether chelation therapy causes increased urinary chromium losses.
  • To determine if chelation therapy alters chromium homeostasis.
  • To differentiate the effects of chelation therapy versus chromium supplementation on urinary chromium excretion.

Main Methods:

  • Comparison of urinary chromium losses between individuals with minimal/no chelation therapy and those with extensive chelation therapy (≥19 sessions).

Related Experiment Videos

  • Assessment of chromium homeostasis based on urinary chromium excretion patterns.
  • Analysis of factors influencing urinary chromium losses, specifically chelation therapy and chromium supplementation.

    • Main Results:

    • No significant differences in urinary chromium losses were observed between the groups with varying chelation therapy histories.
    • Chelation therapy did not result in significant increases in urinary chromium losses.
    • Urinary chromium losses were significantly influenced by chromium supplementation, but not by chelation therapy.

    Conclusions:

    • Chelation therapy does not appear to increase urinary chromium losses or negatively impact chromium homeostasis.
    • Chromium supplementation is a significant factor affecting urinary chromium excretion, independent of chelation therapy.
    • Further research may clarify the specific mechanisms by which chromium supplementation influences chromium balance.